XHKG
2293
Market cap20mUSD
Oct 09, Last price
0.44HKD
1D
10.00%
1Q
1.15%
Jan 2017
-66.67%
IPO
-79.25%
Name
Bamboos Health Care Holdings Ltd
Chart & performance
P/E
28.26
P/S
2.64
EPS
0.02
Div yield, %
10.00%
Shrs. gr., 5y
0.08%
Rev. gr., 5y
-9.46%
Revenues
67m
-10.34%
Net income
6m
-64.45%
CFO
0
-100.00%
Dividend
Dec 02, 20260.025 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Bamboos Health Care Holdings Limited functions as an investment holding entity primarily dedicated to furnishing healthcare workforce solutions throughout Hong Kong. Its extensive array of services includes vital support for medical facilities and tailored private nursing provisions. Beyond these core offerings, the company also engages in providing marketing and consultancy, fostering the advancement and deployment of technological applications, and operating its own chain of aesthetic clinics. Catering to a diverse clientele, Bamboos Health Care assists both private individuals and organizational clients such as hospitals, social welfare organizations, and various clinics. Founded in 2009, the firm's main offices are located in Tsim Sha Tsui, Hong Kong.
Key people
Hiu Chu Hai
Executive Chairman of the Board, Chief Executive Officer · since 2018
Yin Ping Lui
General Manager - Customer Service · since 2010
Financial Controller · since 2014
Executive Director · since 2019
Liling Lao
Internal Audit Officer · since 2014
Huanming Liu
Consultant · since 2014
Wan Ling Chan
Company Secretary · since 2019
Company Secretary · since 2014
Executive Chairman of the Board, Compliance Officer · since 2014
Kai Yue Chan
Non-Executive Independent Director · since 2019
Peck Lim Chhoa
Non-Executive Independent Director · since 2019
Independent Non-Executive Director · since 2018
Yu Lung Leung
Independent Non-Executive Director · since 2016
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||